{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/a4c5de36-8260-4222-8e38-ff997dc73436/67e57c3b2787df76c7762839?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Housebuilders, Isas & Fevertree: The Companies and Markets Show","thumbnail_width":200,"thumbnail_height":200,"thumbnail_url":"https://open-images.acast.com/shows/61b9b44742e856e989985776/1743092704910-867de5c2-26f7-4e86-ad40-879cec1921a7.jpeg?height=200","description":"<p>Dan Jones is joined by Natasha Voase to discuss <a href=\"https://www.investorschronicle.co.uk/content/d5c107a3-d5ea-481c-8e82-c25138fdec70\" rel=\"noopener noreferrer\" target=\"_blank\"><strong>Bellway’s (BWY) </strong>results</a>, and what they reveal about the state of the property market. The pair also unpack the future of housebuilding in light of the Spring Statement and what it means for <strong>Vistry (VTY) </strong>and <strong>Barratt Redrow (BTRW)</strong>.</p><p><br></p><p>Val Cipriani joins to carry on the Spring Statement conversation, but changing course toward Isas and the various takes experts, investors and providers will have on changes to allowances.</p><p><br></p><p>Lastly, we’re back to company results with <strong>Fevertree (FEVR)</strong>. Mark Robinson explores the wider trends in the beverages sector and the company’s deal with brewer Molson Coors.</p><p><br></p><p><strong>Timestamps</strong></p><p>1:27 Housebuilders</p><p>11:12 Isas</p><p>21:32 Fevertree</p><p><br></p><p>Claim your first 12 weeks of Investors' Chronicle Print + Digital for just £12. You will get instant access to our website and app, plus the magazine delivered to your door every week. To start your trial, visit&nbsp;<a href=\"http://www.investorschronicle.co.uk/podcasttrial\" rel=\"noopener noreferrer\" target=\"_blank\">www.investorschronicle.co.uk/podcasttrial</a>&nbsp;</p><p>*After your 12-week trial you will pay just £62 every 13 weeks by direct debit. If you’re not entirely satisfied, you can cancel up to 5 business days before your renewal date and only pay the £12 already debited. This offer is for UK subscribers only.</p>","author_name":"Investors' Chronicle"}